TOVALT ODT Drug Patent Profile
When do Tovalt Odt patents expire, and what generic alternatives are available?
Tovalt Odt is a drug marketed by Biovail Labs Intl and is included in one NDA.
The generic ingredient in TOVALT ODT is zolpidem tartrate. There is one drug master file entry for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the zolpidem tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tovalt Odt
A generic version of TOVALT ODT was approved as zolpidem tartrate by PHARMAZONE on April 23rd, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TOVALT ODT?
- What are the global sales for TOVALT ODT?
- What is Average Wholesale Price for TOVALT ODT?
Summary for TOVALT ODT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Patent Applications: | 124 |
| DailyMed Link: | TOVALT ODT at DailyMed |
US Patents and Regulatory Information for TOVALT ODT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biovail Labs Intl | TOVALT ODT | zolpidem tartrate | TABLET, ORALLY DISINTEGRATING;ORAL | 021412-001 | Apr 25, 2007 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biovail Labs Intl | TOVALT ODT | zolpidem tartrate | TABLET, ORALLY DISINTEGRATING;ORAL | 021412-002 | Apr 25, 2007 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
